Bunker Kevin D. - Insider Non-Derivative Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 20, 2023, Bunker Kevin D.'s relationship to Zentalis Pharmaceuticals, Inc. (ZNTL) is Officer (Chief Scientific Officer), and currently has 834,931 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ZNTL insiders.
Data Source: SEC.
Bunker Kevin D. - Insider Non-Derivative Transactions of ZNTL Common Stock
Bunker Kevin D. - Insider Non-Derivative Transactions at ZNTL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 21, 2023 | G -- (Common Stock) | 24158 | 0 | 834931 |
| Oct 5, 2023 | Sell -- (Common Stock) | 983 | 19.91 | 859089 |
| Oct 5, 2023 | Sell -- (Common Stock) | 5085 | 19.43 | 860072 |
| May 27, 2023 | Sell -- (Common Stock) | 80000 | 30.02 | 15000 |
| Feb 15, 2023 | Sell -- (Common Stock) | 6500 | 19.98 | 865157 |
| Feb 14, 2023 | Sell -- (Common Stock) | 3807 | 20.42 | 871657 |
| Feb 2, 2023 | Acquisition -- (Common Stock) | 91354 | 0 | 875464 |
| Nov 10, 2022 | G -- (Common Stock) | 30000 | 0 | 784110 |